Received: from westeu11-emailsignatures-cloud.codetwo.com (20.93.157.195) by CPH1EPF0000051B.mail.protection.outlook.com (10.167.241.230) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.406.5 via Frontend Transport; Fri, 11 Sep 2026 13:01:57 +0000 Received: from CPH1EPF0000051B.eurprd04.prod.outlook.com (2603:10a6:20b:659:cafe::25) by AS4P189CA0068.outlook.office365.com (2603:10a6:20b:659::23) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.406.9 via Frontend Transport; Fri, 11 Sep 2026 13:01:58 +0000 Received: from AS8PR07CU003.outbound.protection.outlook.com (40.93.65.48) by westeu11-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Fri, 11 Sep 2026 13:01:56 +0000 Received: from PAWPR02MB9807.eurprd02.prod.outlook.com ([fe80::df1c:bb85:2f8:4d19]) by PAWPR02MB9807.eurprd02.prod.outlook.com ([fe80::df1c:bb85:2f8:4d19%6]) with mapi id 15.21.0406.007; Fri, 11 Sep 2026 13:01:54 +0000 Received: from PAWPR02MB9807.eurprd02.prod.outlook.com (2603:10a6:102:2f2::19) by AS8PR02MB8390.eurprd02.prod.outlook.com (2603:10a6:20b:528::14) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.406.9; Fri, 11 Sep 2026 13:01:55 +0000 Received: from MA9PR02MB892294.eurprd02.prod.outlook.com (2603:10a6:250:107::9) by PAWPR02MB9807.eurprd02.prod.outlook.com with HTTPS; Fri, 11 Sep 2026 13:02:02 +0000 Received: from AS4P189CA0068.EURP189.PROD.OUTLOOK.COM (2603:10a6:20b:659::23) by MA9PR02MB892294.eurprd02.prod.outlook.com (2603:10a6:250:107::9) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.406.9; Fri, 11 Sep 2026 13:01:58 +0000 From: "Tegevusload - RA" To: "Luksas, Tautvydas" References: In-Reply-To: Subject: =?utf-8?Q?Vs:_Pharmacy_and_doctors_licence?= =?utf-8?Q?_register_data_for_CRM_use_=E2=80=93_acc?= =?utf-8?Q?ess_and_terms?= Date: Fri, 11 Sep 2026 16:01:54 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/related; boundary="----=_NextPart_000_048E_01DD4436.2447F040" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQJIeDmhS9O/CP2mmSMS1keN4aY41gGSSizEAtRuBIkB+His1QFDE0Cp Authentication-Results: spf=pass (sender IP is 20.93.157.195) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=pass action=none header.from=ravimiamet.ee; X-MS-Has-Attach: yes X-MS-TNEF-Correlator: x-ms-traffictypediagnostic: PAWPR02MB9807:EE_|AS8PR02MB8390:EE_|CPH1EPF0000051B:EE_|MA9PR02MB892294:EE_|PAWPR02MB9807:EE_ X-MS-Office365-Filtering-Correlation-Id: eaace06f-1c52-4139-c1e4-08df1004dc8a X-MS-Exchange-AtpMessageProperties: SA X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|31052699007|6049299003|23010399003|366016|39142699007|22082099003|55112099003|18002099003|4013099003|13003099007|8096899003|56012099006|10067099003|11063799006|4143699003|41050700001; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:PAWPR02MB9807.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(31052699007)(6049299003)(23010399003)(366016)(39142699007)(22082099003)(55112099003)(18002099003)(4013099003)(13003099007)(8096899003)(56012099006)(10067099003)(11063799006)(4143699003)(41050700001);DIR:INT; X-Exchange-RoutingPolicyChecked: RcPWPkx5lXesFEnzeUfXRW5GeZfBvDfNEaooD4gn/BZPFnNcmokR+u+uIkZBeXTjNycXOGVfyE8DJkGesJajtBdLFLMg5By9S6Wmt+WgnRSpa2aVXvpjqSts6Pu5XJjPs++MxfP+wpeNSDjv2MpmiQTXveXqUAP0LiqQiOVfC6rGjvxVb7uLtVVGa1JX8E5LKgDIdQUkk1AcF0VufY0t4gj2rc7/FPINssx7uq+If9x/H6oE+uvYK2WgeLROoGegYJ+irtCa3W+xg9B9TWHhXoBhcQjMao1efk3pQO4vukcCxetagd9Ms6e7mKBGrbAlNM2hYHm7TAO9j0nZDZkPMA== X-MS-Exchange-Transport-CrossTenantHeadersStamped: MA9PR02MB892294 X-MS-Exchange-Transport-CrossTenantHeadersStamped: AS8PR02MB8390 X-OrganizationHeadersPreserved: AS8PR02MB8390.eurprd02.prod.outlook.com X-CodeTwo-MessageID: b1531be1-8fad-4dbf-b686-94f8032a9493.20260911130156@westeu11-emailsignatures-cloud.codetwo.com X-CodeTwoProcessed: true X-MS-Exchange-Organization-ExpirationStartTime: 11 Sep 2026 13:01:57.5894 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: eaace06f-1c52-4139-c1e4-08df1004dc8a X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-Exchange-Organization-AuthAs: Internal X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-Organization-AuthSource: PAWPR02MB9807.eurprd02.prod.outlook.com X-MS-Exchange-Organization-SCL: 1 X-MS-Exchange-Organization-Recipient-P2-Type: Bcc X-CrossPremisesHeadersPromoted: CPH1EPF0000051B.eurprd04.prod.outlook.com X-CrossPremisesHeadersFiltered: CPH1EPF0000051B.eurprd04.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersStripped: CPH1EPF0000051B.eurprd04.prod.outlook.com X-MS-PublicTrafficType: Email X-OriginatorOrg: eegovg01.onmicrosoft.com X-MS-Office365-Filtering-Correlation-Id-Prvs: 7d5fbe9f-0eb8-4728-21cb-08df1004dae5 X-Microsoft-Antispam: BCL:0;ARA:13230040|6049299003|366016|35042699022|82310400026|23010399003|31052699007|39142699007|4013099003|13003099007|4143699003|10067099003|11063799006|56012099006|8096899003|22082099003|18002099003|55112099003|4133799003|41050700001; X-Forefront-Antispam-Report: CIP:20.93.157.195;CTRY:NL;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu11-emailsignatures-cloud.codetwo.com;PTR:westeu11-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(6049299003)(366016)(35042699022)(82310400026)(23010399003)(31052699007)(39142699007)(4013099003)(13003099007)(4143699003)(10067099003)(11063799006)(56012099006)(8096899003)(22082099003)(18002099003)(55112099003)(4133799003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 11 Sep 2026 13:01:57.4970 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: eaace06f-1c52-4139-c1e4-08df1004dc8a X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[20.93.157.195];Helo=[westeu11-emailsignatures-cloud.codetwo.com] X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-AuthSource: PAWPR02MB9807.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-Transport-EndToEndLatency: 00:00:05.1816437 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0406.000 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: 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 Content-Language: et x-ms-exchange-organization-originalserveripaddress: 10.167.241.230 x-ms-exchange-organization-originalclientipaddress: 85.253.204.104 acceptlanguage: et-EE, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-09-11T13:01:54.465Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 20.93.157.195 as permitted sender) receiver=protection.outlook.com; client-ip=20.93.157.195; helo=westeu11-emailsignatures-cloud.codetwo.com; pr=C X-OlkEid: 00000000FBE30D4A7ED77B47974B2304BB4E84D8070034AD76187591974DBF6C4F76951C873A0100020000000000B3D5AF184A00AB4C8C167C2EB8411B9B00000000193D000035788DD378E6704C9EBB8307AAA94D82 authentication-results-original: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; This is a multipart message in MIME format. ------=_NextPart_000_048E_01DD4436.2447F040 Content-Type: multipart/alternative; boundary="----=_NextPart_001_048F_01DD4436.24481750" ------=_NextPart_001_048F_01DD4436.24481750 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Hello! The State Agency of Medicines does not maintain a database of doctors. The database of pharmacy activity licences is constantly updated, so you will always find the most up-to-date information when visiting the page. Sincerely, Triinu Margens Specialist Bureau of Inspection State Agency of Medicines +372 737 4140 www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. _____ Saatja: Luksas, Tautvydas Saadetud: reede, 11. september 2026 14:19 Adressaat: Tegevusload - RA Teema: Re: Pharmacy and doctors licence register data for CRM use – access and terms Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Hello, I'm reaching out to you with another question. We’d like to make use of the open database of doctors also. My question is: can we use doctors and pharmacy lists as a database so that our representatives can select them? Is there an API key that would allow us to connect directly and automate the updating of the lists of doctors and pharmacies? Thank you very much in advance for your response. With Best Regards, Tautvydas Lukšas Data analyst Bionorica Lithuania UAB Šiaulių g. 10-57 LT-01134 Vilnius, Lietuva Phone: +370 659 50801 E-mail: tautvydas.luksas@bionorica.lt The phytoneering company Cistitas? Akmenligė? CANEPHRON Atsibodo sirgti? STOP peršalimui! Šiame elektroniniame laiške, įskaitant bet kokį jo priedą, gali būti konfidenciali ar slapta informacija. Jeigu Jūs šį laišką priėmėte per klaidą, informuokite mus apie tai elektroniniu laišku ir šį elektroninį laišką ir bet kokį jo priedą pašalinkite iš savo sistemos. Bet koks informacijos esančios laiške panaudojimas, kopijavimas ar platinimas yra griežtai draudžiamas. --------------------------------------------------------------------------------- This e-mail may contain confidential and/or privileged information. If you are not the intended recipient or have received this e-mail in error please notify the sender immediately and delete this e-mail. Any unauthorized copying, disclosure or distribution of the material in this e-mail is strictly forbidden. _____ From: Tegevusload - RA Sent: Monday, July 13, 2026 4:06 PM To: Luksas, Tautvydas Subject: [EXTERNAL] Vs: Pharmacy licence register data for CRM use – access and terms Hello! Thank you for contacting the State Agency of Medicines. The Activity Licence Register [rkav.tehik.ee] is a public, free-to-use website that contains up-to-date information on current activity licences in Estonia. You can search for pharmacies, but please note that some pharmacies may have branch pharmacies (usually marked as HA[number]). Information about branch pharmacies can be found under the activity licence of the main pharmacy to which they belong. To view this information, open the main pharmacy's activity licence by clicking on the activity licence number. Alternatively, by selecting "Consolidated data for pharmacies", both main and branch pharmacies will be listed in separate rows in the Excel file. If you have any questions, please feel free to contact us! Sincerely, Triinu Margens Specialist Bureau of Inspection State Agency of Medicines +372 737 4140 www.ravimiamet.ee [ravimiamet.ee] Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. From: Luksas, Tautvydas Sent: Wednesday, July 8, 2026 12:57 PM To: Ravimiamet Subject: Pharmacy licence register data for CRM use – access and terms Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Dear, We are Bionorica SE, a pharmaceutical company operating in the Baltic markets. For our field force planning, we would like to keep an up-to-date list of Estonian pharmacies (name, licence holder, address) in our internal CRM system, based on the Activity Licence Search available at rkav.tehik.ee. Could you please confirm whether we may use this register data for that purpose, and whether it is available in a machine-readable format an open data endpoint rather than only through the web search form? We would also appreciate information on any terms of use and how frequently the register is updated. Thank you in advance. Best regards, Tautvydas Lukšas Data & Analytics, Baltic Markets Bionorica SE With Best Regards, Tautvydas Lukšas Data analyst Bionorica Lithuania UAB Šiaulių g. 10-57 LT-01134 Vilnius, Lietuva Phone: +370 605 65 188 E-mail: tautvydas.luksas@bionorica.lt The phytoneering company Cistitas? Akmenligė? CANEPHRON [canephron.lt] Atsibodo sirgti? STOP peršalimui! [stoppersalimui.lt] Šiame elektroniniame laiške, įskaitant bet kokį jo priedą, gali būti konfidenciali ar slapta informacija. Jeigu Jūs šį laišką priėmėte per klaidą, informuokite mus apie tai elektroniniu laišku ir šį elektroninį laišką ir bet kokį jo priedą pašalinkite iš savo sistemos. Bet koks informacijos esančios laiške panaudojimas, kopijavimas ar platinimas yra griežtai draudžiamas. --------------------------------------------------------------------------------- This e-mail may contain confidential and/or privileged information. If you are not the intended recipient or have received this e-mail in error please notify the sender immediately and delete this e-mail. Any unauthorized copying, disclosure or distribution of the material in this e-mail is strictly forbidden. ------=_NextPart_001_048F_01DD4436.24481750 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable
Hello!

The State Agency of Medicines does not maintain a database of doctors. = The database of pharmacy activity licences is constantly updated, so you = will always find the most up-to-date information when visiting the = page.


Sincerely,

Triinu Margens

Specialist

Bureau = of Inspection


State Agency of = Medicines

+372 737 4140

www.ravimiamet.ee


Selles e-kirjas sisalduv teave (kaasa arvatud manused) on = m=C3=B5eldud ametialaseks kasutamiseks ning seda v=C3=B5ivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma = saatja selgelt v=C3=A4ljendatud loata edasi saata ega mis tahes viisil = kolmandatele isikutele avaldada. Juhul, kui Te olete saanud = k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, teavitage sellest koheselt = saatjat ning kustutage e-kiri. 
This e-mail and any attachments transmitted may = contain confidential and privileged information. If you are not the = intended recipient, please notify the sender immediately by = returning the e-mail and permanently deleting what you have = received. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal. 



Saatja: Luksas, Tautvydas = <Tautvydas.Luksas@bionorica.lt>
Saadetud: reede, 11. september 2026 14:19
Adressaat: Tegevusload - RA <tegevusload@ravimiamet.ee>
Teema: Re: Pharmacy and doctors licence register data for CRM use = =E2=80=93 access and terms

T=C3=A4helepanu! Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.
Hello,
I'm reaching out to you with another question. We=E2=80=99d like to make = use of the open database of doctors also.
My question is: can we use doctors and pharmacy lists as a database so = that our representatives can select them?
Is there an API key that would allow us to connect directly and automate = the updating of the lists of doctors and pharmacies?
Thank you very much in advance for your response.


With Best Regards,

 

Tautvydas = Luk=C5=A1as

Data analyst

 

Bionorica Lithuania = UAB

=C5=A0iauli=C5=B3 g. = 10-57

LT-01134 Vilnius, = Lietuva

 

Phone: +370 659 = 50801

E-mail: tautvydas.luksas@bionorica.lt 

 

The phytoneering = company

 

Cistitas? = Akmenlig=C4=97?

CANEPHRON

 

Atsibodo sirgti?

STOP per=C5=A1alimui!

 

=C5=A0iame elektroniniame lai=C5=A1ke, = =C4=AFskaitant bet kok=C4=AF jo pried=C4=85, gali b=C5=ABti = konfidenciali ar slapta informacija. Jeigu  J=C5=ABs =C5=A1=C4=AF lai=C5=A1k=C4=85 pri=C4=97m=C4=97te = per klaid=C4=85, informuokite mus apie tai elektroniniu lai=C5=A1ku ir = =C5=A1=C4=AF elektronin=C4=AF lai=C5=A1k=C4=85 ir bet kok=C4=AF jo = pried=C4=85 pa=C5=A1alinkite i=C5=A1 savo sistemos. Bet koks = informacijos esan=C4=8Dios lai=C5=A1ke panaudojimas, kopijavimas ar = platinimas yra grie=C5=BEtai draud=C5=BEiamas.

------------------------------------------------------------------= ---------------

This e-mail may contain confidential = and/or privileged information. If you are not the intended recipient or = have received this e-mail in error please notify the sender immediately and delete this e-mail. Any unauthorized copying, = disclosure or distribution of the material in this e-mail is strictly = forbidden.

From: Tegevusload - RA <tegevusload@ravimiamet.ee>
Sent: Monday, July 13, 2026 4:06 PM
To: Luksas, Tautvydas <Tautvydas.Luksas@bionorica.lt>
Subject: [EXTERNAL] Vs: Pharmacy licence register data for CRM = use =E2=80=93 access and terms
 
Hello!

Thank you for contacting the State Agency of Medicines.

The Activity Licence Register [rkav.tehik.ee] is a public, free-to-use = website that contains up-to-date information on current activity = licences in Estonia.

You can search for pharmacies, but please note that some pharmacies may = have branch pharmacies (usually marked as HA[number]). Information about = branch pharmacies can be found under the activity licence of the main = pharmacy to which they belong. To view this information, open the main pharmacy's activity licence by clicking on = the activity licence number.

Alternatively, by selecting "Consolidated data for = pharmacies", both main and branch pharmacies will be listed in = separate rows in the Excel file.


If you have any questions, please feel free to contact us!

Sincerely,

Triinu Margens

Specialist

Bureau of Inspection


State Agency of Medicines

+372 = 737 4140

www.ravimiamet.ee [ravimiamet.ee]


Selles e-kirjas sisalduv teave (kaasa arvatud = manused) on m=C3=B5eldud ametialaseks kasutamiseks ning seda v=C3=B5ivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat = teavet ei tohi ilma saatja selgelt v=C3=A4ljendatud loata edasi saata = ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te = olete saanud k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, teavitage = sellest koheselt saatjat ning kustutage e-kiri. 
This e-mail and any attachments transmitted may = contain confidential and privileged information. If you are not the = intended recipient, please notify the sender immediately by = returning the e-mail and permanently deleting what you have = received. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal. 


 

From: Luksas, Tautvydas = <Tautvydas.Luksas@bionorica.lt>
Sent: Wednesday, July 8, 2026 12:57 PM
To: Ravimiamet <info@ravimiamet.ee>
Subject: Pharmacy licence register data for CRM use =E2=80=93 = access and terms

 

T=C3=A4helepanu! Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.

Dear,

 

We are Bionorica SE, a = pharmaceutical company operating in the Baltic markets. For our field = force planning, we would like to keep an up-to-date list of Estonian = pharmacies (name, licence holder, address) in our internal CRM system, based on the Activity Licence Search available at = rkav.tehik.ee.

 

Could you please confirm = whether we may use this register data for that purpose, and whether it = is available in a machine-readable format  an open data endpoint = rather than only through the web search form? We would also appreciate information on any terms of use and how frequently the = register is updated.

 

Thank you in = advance.

 

Best regards,

Tautvydas = Luk=C5=A1as

Data & Analytics, = Baltic Markets

Bionorica SE

With Best Regards,

 

Tautvydas Luk=C5=A1as

Data analyst

 

Bionorica Lithuania UAB

=C5=A0iauli=C5=B3 g. 10-57

LT-01134 Vilnius, Lietuva

 

Phone: +370 605 65 188

E-mail: tautvydas.luksas@bionorica.lt 

 

The phytoneering company

 

Cistitas? Akmenlig=C4=97?

CANEPHRON [canephron.lt]

 

Atsibodo sirgti?

STOP per=C5=A1alimui! [stoppersalimui.lt]

 

=C5=A0iame elektroniniame lai=C5=A1ke, =C4=AFskaitant bet = kok=C4=AF jo pried=C4=85, gali b=C5=ABti konfidenciali ar slapta = informacija. Jeigu  J=C5=ABs =C5=A1=C4=AF lai=C5=A1k=C4=85 pri=C4=97m=C4=97te per klaid=C4=85, informuokite mus apie tai = elektroniniu lai=C5=A1ku ir =C5=A1=C4=AF elektronin=C4=AF = lai=C5=A1k=C4=85 ir bet kok=C4=AF jo pried=C4=85 pa=C5=A1alinkite = i=C5=A1 savo sistemos. Bet koks informacijos esan=C4=8Dios lai=C5=A1ke = panaudojimas, kopijavimas ar platinimas yra grie=C5=BEtai = draud=C5=BEiamas.

------------------------------------------------------------------= ---------------

This e-mail may contain confidential and/or privileged = information. If you are not the intended recipient or have received this = e-mail in error please notify the sender immediately and delete this e-mail. Any unauthorized copying, disclosure or = distribution of the material in this e-mail is strictly = forbidden.

------=_NextPart_001_048F_01DD4436.24481750-- ------=_NextPart_000_048E_01DD4436.2447F040 Content-Type: image/png; name="image.png" Content-Transfer-Encoding: base64 Content-ID: <2fb01ee8-ea02-4fdb-8904-25747dbd6d09> iVBORw0KGgoAAAANSUhEUgAAAJgAAAArCAYAAACEnEH6AAAAAXNSR0IArs4c6QAAIABJREFUeF7t nHeYFVW29n8VTuqcaJqmyTQZJCOgKKbBHMc05iwGTOA4hlExx+uY0zjmiDlhVnISBRSQnDvnPqnS d9euc6BhmOs44/3m/mE9Tz/dfU7Vrl1rv3uFd61Vmut5HqlDS/+lfqf+ceW3C4auznI9F00z0DQN x3VwcTF1HQ0tNYqcv+PHw0NDrg3437upn/S95Cvd8j/U5B8ZR8PzNHUPuXr7/Lb/1eZWOKkB5TI5 Vw24fQZypj9i+pk88GQSqQloRuqaXQff3c22iyp1fXrkHXP8uVH+97/faRHTK7vL719jFuk13nWs tEzkew3NSQFMfdwWG+kFsB3wbAiaapVc18HTTDRNx3JtXGwihgnIQqXAuBOKZDHl+7A/E8GD4Cl9 L7ksEAPNAs3A8wS8Op6nKyALwPyppkHS5oHUGDKYXKulAOrPpQ2E1LX+9pALUs+jQKaBLsCXa37u SD9b+jy53gfzbmb2c4P9L36/0yK2AdZuJfhvzGNXeaSHSssjDbCUClOLoOYmO1z+Sw0gGkwWw9Dw ZBF1iNsuluthBk0Cos3UKR4J2yVqJ7CcpNIqcitTDxAyAgQNE9M0Mf2VBhu8hP+HFoqD4eC5Grbt YphBND2IozCgoysNmdoAu4rElXslUgCTTWDiYe4WYJp8KptF/QjSddCDoAXS2+nvBL5DN6UgqxR+ +kdA/c9qwH9jLf+HS9P6aicNLfPbYZj8DaC0+866XIb913VvyhS1tXZqnkbqXv7omuv4M1E32m4B 0mZEPvI/dGTxxdgFdFwNLNclYTlsrGhlzYZGautaqaquZ1tFDQ3NTdiujaZ5RMIB8nIitC/KoVvX Esq7l1BWlEFuJERANzFcWWjRhN52Darpupqk64qZFIDJIqaOtlZKzdkGTcZIazBf6+1Og/m6UECW ttNpgLQZf5fb7FiANsBKaz8Z7z8MsJ2x19ZstRVU+in+N7TYTsBpA+KUBvMEYDtvg9Qi+CeIMrMV 9mS3+xaupiXB0uUbWLx0JQuXbeHHdS00trrEYnGiUQvb9tBMg2DAUCbM9VqIhG2KCk06lETo3jWf 4cP6stceQ+iR156MgIkjGsXTMJU3JyBw0HXfD/M1asrQpZSrfLRj1/pibuuv7d5E+uf5QEsL5h8L PW2a/x7dKfOqxvm/ZCL/kV+UfoJfG2C+S9322NkDE6ujAJYS+HY1JjsTXE3D9nRszfdSmpMOC1du 5tMvFzB77ves2bCNRgsSgSwwxdSIJhAzZaBrOqYEAp6D4ybAjYMXA6sZvDilZUUM7NOb/UeN4MDR e9CjXY5aqkTCJqRBJKCji3ZKO/8KUTJBU+FtV08jbXl/TuXvYuCU59hGdbeR1c4j7ao42y7ZLjL+ D//7j2bqb61f80jbgbZjtt1uvlvjuN52GOoSyfmnO2IG8aNDGWhdbQsffDafae9/xfKfNuNqYdBC xAwDNzOofDRcUYZp+y+/BRN+RKd5ogP9c9ykhWc5oLl0LIqw3579OfbQfRjRvzNZpobpuoTENLoW mjjxempSKQB7mr7bYDTtzCsN1TZSTJnPtqYzrYNk4/hPuOuRhuwOXZeGYluF/+vrhH8fAmnNu+vv f3/knXW5WLNd4Zz2SNP31jzb2aHB5Hpdw9EFXCnReR5LN23jmWmf8eZ7X1NZGyOQUYimZ4IWxgsF cAMurmfhKX/KB45EDJqYOAGd46GJ4yaq0DMJmGF0AiQSSdx4NeFgnD0G9eTkYw7lsL37UZphoLuu 8s8MPTWmejbRjgHSAEs/oMw0/WA+uFLXKJD5gYIyZZpElzvAmRoxFWGmhdfWzOzsFKfNbhsXX2n2 X1cv/BIY/L2f9Y+MZFsvbGdY/GuzT3mzO0027TCItHcAzNoBMGV6dI2kaAhNFs3j6yXLeeiFt/lq 3g80N7sEsooxQgUkYrqiK4yInNWCJyGhUlp6SuH4dsy1HAzNIBzOwHVc4vEEhkSUWgDbsjBCYFmN uPFGevXswilHHsBJB4+kW04QXTg3FW76XqCHUBgGnlybYjzSRIHnupjKisokbHDF+RdfToCVBpkf ZcqoCnpKw6YiZwGp8G7KY3CU7+d/J1HRDgImLdi0AIXk+NeW6JcAaffnetu1dIqEUbzhTjGur2E8 0d2aMjL+Inm+nP5N/1HJwhUZeyrSF4H54vSBr2ToiUfuqhhOCd0Sv0kX8Hgs+mk99/31NT6ZuQhL z0IP5eMQwfMy8MhQE9T0ZjytDrwkGgE0IhgE0dwQuCaOJTpDJ5gRwnYSOE4UM6jjOUlc0XaGge1p 6J6F01xNt/a5XHL60ZxyyCjaRWT5UryVzFEoE8PE04MkHH+Jhf8VYCUTCQK6Jl/75tER0+qbaZ8j E3AJvyaBi5ykkxoCy3HQNY2gIfNycF1bUSoyjqYiWJ/wTWuw9G8R5n8OYLJsTmoxU26I7vN/dho7 Cm0SnfvuiVBEruMT04bhb9Z/7/Cwk0lFuAcCAT8gUy6R7EgfdJrnuZ5jWUqw4qhbhk5A0/hucxX3 Pvka07+eT5NtYGYUQCAH2wvgOiaeY0oUALSCHvXNoRbEs3W8pOyoEKYRwdBNHFGSrqUAJbymptk4 iRh62MALhRRFQbSRgNuClmyid2keV5x3AkcfMJxcQ8d2bHTNUyCQB3A8DaV4BWC4BARlKgp1kWcx TAG+PKQrEvWDDwUYTQlYQKabEiwYKirebmgcTwE2nQfQZHeqDIbv3cl56bzB/wUNJkDxNa7QSCIa sTwSWPmKW3ksHgSVEvZwLBvPcQkGDRWhKwWh1PS/cvgA97WhaC4Px7bRDBPdCKh5+RrMczw5UVSd I6uv6zQkbZ564yvufeR56pvi6AUdIJCJpodxxUSl3SJxxGXhxKRaNlgJcGyQYEHZLtEwhgIY8STo JkQy/S0mTn4gAOGgcq10N07Ai2E3V+E2VXLAmCFce+mZjO1fhiPaSwSlawpktpKcT6HI/UxDBKUr HzAeT2IGgwTM1O70PFxP0lq+P+YDKK3VfIDJjxxJ2yNoaAQkFrEtDN+mtCEOfQ0hPyma9j/rg4kG S3FxtorVNDXntsZPaGj53/RE2wjAHMIhcWt898EwUym8X4gxAZArG1/JXtZYNq7ra/6U16EA5jiW b6Z1A8vTlB8+fd5P3PHgSyz6cT1GViFaOAfb1fzATOxRiqdSmRYcPCcBdisBI0YowyKSYxMIxXCd RtASBAImrqvjeiE0IxPbDqPrEWKtGo21ITy3GDMrT/lhAasZw2nFTDRw1olHc8mZR9AxL6J2pSk/ sjNdW6l82YWyORzHVUDXVWrJP9pGeio75bj+7jUNP5vgeUoLrtpaS01jKx07FFJSkENQTK4MIESx 6EiFsR1AEz8wrcnSwcW/qgN+4ZrucrpYBccnpw0/c6GA73pU1DRRUV1NZlaEDu2LyAyHfB0sPqe6 xj9bgKErn+KXH7LhVbJMg3jCoqa2Xmmw3Pwc8rKztvulmu1YyiWzNUOZxg2NMW57+C2ee+0TvHA+ kcJSEq6OlbBECaIJSaUn8BKtYEfBqSYSrKFjSYDO3bIpbu+SldtEMNxAMNKC7TSgS0RpBElYIZLJ CK6TQzhcyKq1rSycF6axpj94eegkiYQ8vEQjXryRrqUFXHXRqRy97xBCqdAkIBJ1LOWwyuIL22/Z DroZULRKzJJ0lUtDLKlAJZo5IxyiXW6YbGNHtGlbNpU19dz/2HMsWLKC439/NCcfcwB54aASjojd teMp57UtyCQVtYOq/Y/SFJ74paLFdDTD19hNCYu33/uM5158kY5lnbjkwrMZ3q8nrbYk0DzCpq/p /UDGSPmYvxxgaT80Ydts2FrNmjUbaW5soLSsI33Lu5OfGVJWRHM8xaGr8F2E9eHsH7nxvpdYuqqa YG4HCOeRVNxVEkwXLSiqtQUv2QROMx3a1TGkdwP9yk06dcolKyuJ41RgO9UEwwnMgDiUAeIJg7gV AS8fz8klFCxk4ffbmD4jzObqIbjNISJZQTTTJVpXQbu8DOItNRzxu/FMufBYehZlqR0TFFlYCUVf +MUT4sMZJF2Y890K5ny7gq11zWytaaY1IYl5naKCXAb368qIAd3o362UvJCmotv1W6u48trbmbXg eyZecDYXnXc87TLDivIQbYmbTKXw0vpQIiVB+r/rHP/yBd3tFUJii5MtYjDDSp00x5M89exr3Hf/ A/To1ZNbb7qWvYcOoCXpKtMvBPaOdFk6VfbL55NKzrGltp5FP6ylsbGVWLSF7Nx8upaVUN6xgOL8 XDTbc5UGE/O4tirOEy9+yHOvf0hcyyWYXUo0aaAMkmfjmXHl0GPVEQxEKS502WtwgrEDK8nLrMDT hVJIYotmU2ZMLJGOZxs0NMSUeczL7Ygt2sooYOHiat6fZbC5vj/o7QiGDGwrDk6ciOliRevp26MT 111xKgcN7blds+gKYJYykZ4WwsYk7sJfnnqVx5+fRlPCIZRdgBnKUo5vY30tpptk7IghnHHikew/ qic5hq5SXrO/XcbazTWM3KMXA3t3JmIYKlXuWA4hSXVtt39pXZV27/1wfIePvMNQivB3B8E0haCK CoRCSdvy7Ynov19o/24pbk9WSuiA1OgSHCUtS0XP4lgLdSPKYPGPq/huyQ+UdShmzyGDyM3NFqIA Q/PpCfG6JNOy69HWrdjxlLsHn9SwyAibaupZtGwtScvFsS3MUISOxQX06ZhPu/wcNDvpeeLb17ba vP7pSp5662O+W70UPZxLMNyRRDSIQwg9aOPpDXhuHUQ30bG4hX1GhhjRJ0pJ9hYsdxstXpKk1HEF MsnPKcOJBVj34xZaaurIyoxTXBIiJz+fuJ6P7ZaxYInDp994bK3pjhYpxRXA2A5G0MBNtBJwomSZ DldOPIWzjx5LnpkycXYCTRMq2MPTBWBBYhrc/+Q0Hn3mdbqW9+K4YybQpaRAOZ8Ll6zhrXc+oqW5 iXGjhnL95acyoKxYajCUVhRHOEuWzYmlKA4XVw+rIETAkhA2RRxYXVOBRhpKoj10Q6JUk6QbUHY1 HZWGxO1wwRYKRBzhVDZCmV/bxhOfVcI74dmMiFpFVXikuBO/Nk42kKpmkv+TjWBFIZSBZ2aTxCSW Wnu5l5ghuVTiqDgOJjq5qZnGxAJpwm/6dFSGUBZqfh6O5yr+L6gLmZTm0Pysrh8byjNYCqAqiDBN 5Z7IXOWcZNJmw+YqtmzZQlNTE+07lNKrRzcKMoMEJZp3Yp4nstxQ0cLtT8/m1a9n0+huwjMD6Fp7 vGgGaJkQEinX4nk1hKxNDO9Vx1EHQMe8GrCaSOgWNXYcJ5yPG+hAU12ELasbiFXW0iHXpXvnOO3a xxB2o5VCom45C5aYzJplUlPbFUsvwlGc047oz/Si2A1bOeeEI5hy3uF0zwuhu8LrSP2X5cfmeoAk IeKGxgPPvMvDT73O2L3HcvMfz6RvnoAPKhLw3Btf8vzLbxFrqufBO//IkaP7E7Vtpi9YTjRuMax7 B3q2i2CKj+kZOGYWa+qTfLtqG2vWrqe1toJs06VPlzJ6du1Czx5lhE0XNxlFM0Osqoyx4MfVRLKz GTKgO+vWbGPZkiXU1TcQzsqiQ5ce9OnZmf6dcwk5FnqiWZU7YYZJekHWVDbx7dIVrFu/jqRtE8jI pEPHLgwb1Ju+xRmE3WZINqlHXra+iW8r4nQq70pxXhY/LlrJ1tWrKS7OZ899htKSbOSnlUtoH85l QNfe5BUUEtchhiakEpvXVbHmx1Vsq66iKRolKyPMwL592KNPdwpzIkrTJZIOGzZu4YcflrNpy1ai CZtAJJuSTt0YMnggPTpmqgo/0YZWMkllZSVNTc20LymhqLBgu9rzk906LF1Vy58e+JiPFi7CyWyC kInm5uNFQwpgWkjkXoum1VGS1ch+Q5vZd0Q1ucEqkjGbmtYYrWaI7A6D2bApxJefrsRqtBg5IJdB vZPk5mzFDDSS8ILEvTKidGH+9wlmzTKorS7H0dsrgAk3pZSv52B4MZymbUwYM5gbJp3EyO7tlYbT SKeQhHmXCDhMQoPbn3qTB594jX3G7c2fJ59CeftcBTARwvtz13HtzffTULONh+++iRP26ceWumYu ve1plq/fyqRTD+fE340kN2wScw0Wrq7kjenzmP7NImqqa3Fb69ETjXRsl0PPHt059MgjmLDvMEoj jgouPv92DVPveVLpjvHjRvLtvAWsX7VaCb/V0cgsLGbffcZw7smHMLRHMSGVndBodAymz17GtA++ YtG331FXU4luBHGNEKHsQsbtO5aTDt6Tffp1JD8CrS0tPPjy5zz2wXyGjxxFSU6IGe98TNXaVYwc O5TJN1zG6k0reeyRxxnSvQeXnnEavfv2JApsizp8Pnc57772LisW/0izZWOJyfVsivOymXDQfvzh +IPp3a2AZcu38cijzzJr1hxcTeYTxvIMBbK9x4/nzBP2Y2zvPDLTNQiK3xZiemfTq3kpXn/G4o1M vvMN5q1cA0UGmhRHeBHcuIFOBC0olEA9UE2PMofD9rYZ2H0FEXMbrVGbygYI5vaiJVnGhx8vZ8O6 asaOGMCQfiGyQz8RDmwhGErgGGFsszNRtzMz5zcyc1aQxob+eHqJz7GpBxYtYmN6cfRYLUPKS7nx 8pM5cHAvXAUwSQs5yqkVH0/sQhSN2598k8effYfx+47jhitOpU+BmHeoScJTr3zBA4/+jR7dOnPL NRM5cGAp66taOefGx/hy4VKuufg0LjppPIUBjcVr6/nLM9N499MZZOUWMnLIAMo75hNtqGHFitUs Wrqc9l36cMl5J3H2wUMImDB3+ToumXInK1ZvpGNxEd2KcxnYrye5ubmsWL+VT2bMJxAMceqJR3PV BSfSPoLyGz9etJF7HnyOhYsWMaBvL4YN6EFubg4VjTFmLPqJTVtrGD96EFeecSgThndXvs7dr3zO n//yhsrploQ0lVbrWJDJgKEDOeqkg/l05hxuvvkhRg/oyW1XX8igAd3YmoDXPvqeBx9+lsp1axnc vzd9BvYmp7CQjRs28M3nn9GpU2duvv4yxo/uyVdz1/H0X18nmogycMhQMnOKWLOpik+/mEl1dT2n nngw110wgR7F4lz4KSM/vbYzaaOIVtlJ0+f/yB/vfpvv1tagFYbxdPFzpABMiLSgX4PvNIO7jX7l Bscc6NGjeCGWsxZHopdYCes2dGDB4lo2btvGHkPKGD2yI7lmkpDTSlCrQTdrsIIWTqiQmF3ONzN1 Zs0K09jYB1cv9sGldoAPMMONE7IaKO+QzU1XnMxhowb5jrUnbJRoAFF24idp1Htw31Pv8uwr79O3 bx9OO/YQepbmEI3HWLRsDW9//A1xR+Oc04/nkDG9Kc0Osq0uwaS7n+fTBT8w6dyTOee4ESpKffqF T7nvsefIzS9UYf7+I7vTOS8T17JYtr6Sx176lDc+mMGgPcq5f/IfGDOwMz9sq+HK6x9WABw9dCDn n3QYQ/t2JhAIsqmuiUdfms4r096hX99y7p16NYM757B4XTXX3f8Gs+cvZuSQflx+zjHsWd6eYDBA Xdxi+nebuP/RN9m4chln/+Fwrj7/KEpzAjz31Y9cdefrJOvrOGqvQVx44oF07ZBDJDOCnh3i2ffm cec9zzO0dzG3Tj6DIX068+nSSm644yXmzpnPiUfsx2VnHUy3zhJYhaisqmHe3AUqyzF+3Ci6dGxH RW2UmtpGMjJD5BcVKN+ustHi9Q8X8Nhjz9GhKMK9N1zA3sN6K4I1HQ3tBmAJcQ35cP4yrr33Pb5b 04iWn4UntVvSjKGaPCTHKCy21HVVsEdfnWN/59GlaB4JZx0Eslm1OptPPo7RHNcZNrYjewwLkRWp wIiZZDrt0JOtJLxNJIONuJKXdAcwb04+X8+IUFXXA08v9FnUtKspAPPiGNEaepZkMXXyaRw2eg/f QxOAbY/CpF5No9mDh178hIeefg3LStK9QzFB16KxsZaK6lqcYDbHnngyl114FN0zfNKxuiHKxbc/ xawl67j8wrM46fCBbNrUyI0338f8b5cxaeJ5XHzG7yiV9FaKuhUwv/d9LZfd8gSVFZv509mHcOFp h/Ldhnqm3vk4FZu2cuXE0zjt0OHpLgS1Fd5ZuJrLrrmb7Jwsbp5yPvuP7MWr079n8i2PUVhUzDWX nspp+/XEd/f9o9KD/3ptPnff/ggDu5dy29Xnsc+orrw9eyWTb3uVwrDBrZefxOFju2+vX6h24Zn3 vuOBh15mUHket045nfJOJdz97Afc/cDb9Os/gFuuOpGDh3ZAWnbEPimROi6O+IaSAVH1fLunj2dv aeXqa++navNP3HvtxRw2fqRfRSPZHNf1849trtU8Lyb8OJ8sXs6UO97i+xWNUNgO3RBHulkCYTRJ Drt+esETgPV3OfpAl7K8hQRCURpaivniy3pWrXTYY1gPBu1pogVXgl1BxMkmkizFsDxcs45EqA47 qGN7/Zg7J4dvZmZQ1ViuaApJfPsAE64toTQYrVX071TE1CmnccCI/n5vku1gGn40J2ko1zSIA/c+ +yEPPy2mI0CvLh0IajHisTitUYdN1U30GjCAY484kMPGDaBbToCNlQ1ccftjzF2yismXns/vDxvJ V19/x9Rb7yIcyeTuqddzwNDOmJKtiDejiYedWcCqxiST7nqd2XMX8fv9+3P9lLP4aWsLN9/+OFvW reemyedx3P6D0KSgQzIPOsz8aRMXTfmLiuaumXQ6+4/ux5MvfcEDT7zKXqOHc+fVZzKovQHxVrXY sqndjAzeXbqV6256gpaKddx4+Vmceuw+vDnjR66541k6tcvmrqvPYETfYhJuLZqeR5MX4en3F3Lf X15k2IB8bplyNjmZuVx9x8O8+e4CzjrzXK4650BKcyyspEVmMKiiSD2V9BI6XWJIceAlSq1obqW5 JaqqlaXAYPHGOh55+jWMWAMP/PECfjdqkEp6ih0UgEmqaDcAC/HNstVMuftN5n1fi5ZZhBbR0QNN uHaLT5l7QZBsfXIrPXs0cdh4h75lmwjq+SxdlsMXX60jIyPInuMKySpajeWsIqB7RFyTXKM9kUAY zCiJQCteKIvmaDc++9xh1rxMYu4gCLRXuS3lfxkSotsYThRaqhjTvyvXTjqZvQZ299M40umk0jh+ HY1nGkqD3fn4W/z15fcZMngw5556JP1KwiQ8jcrGJG9/PJt3PvyUzFCIKy44mdMPHUldXSuTb3uE L+d/y1WTLuCkI/fl3fc+5577H6R37z7c/McrGdKzPQGtVUXKKrkfKWZTU5wr7n+Pj7+czYTRPbnz 1olsq2nhqj89QuXmrVx94cmcfuRogqm6x6QBM1Zs4fo7nqE1nuTqy85kaL+O/Nejb/Hsy+9x/BET uPuaU+gQSEJLNQgZqmfhRLKZvb6Ze/7rRebPmM41E0/m0rN/z7Svl3HtnU+pYs1brjyD0XuU4nhV uFoRTV4uz3wwj1vv+xvDBuZz2zUXKhfnz3c9zDez13DuOecz6axx5JJQhZ2eoalWREMcec9UjyjU xLbKamYsWMysb5eyYWsNzXEPMzOXusZWNqxYweABvbl/yrns3a+rsih+4UYqwb2zBpPMs8HiVVu4 4dH3+XTORpJuNkZWBF3A4AhjL8o0iBeSmq5t5GWvYcIYj4NGZ1G1McjHHzpsqWim70CdQcMThLNX oLGVkKERdoNkmFkYAY2kE8cJRjAjXdm8pYgPP2xi0bIIbngQergdTkJqyjwIGIimNqwm3KZtHLrP CK6+6ASGdS32K5g8sG1LkYVSdiJCaQTu/+sHPPnCu4wcMZSbppzK4MIMxXUJz7W6LsY1Ux9jzow5 HHHAGG6bfBbhYIQrpj7Ip3MWcuUl53LSUfvw8fSZ3Hn3A3Tt0o1brpvC8PJiTHEX7CafZAoUsLEp xmX3vMMn38xlwuge3HPbxWyqbuCSK/6LaF09V55zAmcevRfBVEGHFJeIP3XTPU+qzqs/Xn4WQ/uV cf8jb/Hcqx9wzKEHcduVp9Atx4bWeiHdwMjEDWXyzfoGbr39WZbM/4rrJ53KxWccw7SvlzDl1scp Kwpz25VnM3ZYJzwqsWhHI7m8+OEibrzrKQb3zeWuGyYSMDO4/q5H+OzL5Zx5xplMOfcgikO2skiu Zyg+TPK4hu7zY2sqanjy+df4+NOvycgtpqBDBwKRTHLblVBT18S3cxfRv7wL9151GqPKO26PHv3K jlRtWMrMa9K1JqZmXWUDd7/wCa98vISmRA5GKIJrN2AGbfT/Fko84eFlZeHpVQS8pRw8NpsDRrRn zldrmDsvQXn/MkbtbdGuZD0aa9GdZsKatKyZyglMOHFcXaLTrjQ2d2fJ95nMnGGxsTILO9QBLZjl L6BEhq6FIflGpxmnqYIzjz1UpYu6FWSo7SU8jQp+U4V0qgJEnPy/vssTz73NiBHD+fMVJ9K3tICE 67t2EqZfc+fzfD79C4b36cpd115EYWEBE298iM/mL2PSBadz8lFj+X7Jem66+Q6amlqZ+udrOHZ8 PyJSOWBF/coRPcT3VXHOv+lZliz9gTOP2pNrrziZDRV1XHzVvTRUVnPNxadz2hFjFcDkEIBP/3Y9 19zyoOrMuv6qcxk3spynX57JbQ88w/Ahg7ltypmMK89BFy1uJXF1k2QwyCvz1nLtdQ+T6Ua5/Zpz OeqAobzyzTKmTH2azoUR7pp8BnsP6wbU4ZJHgxviqbcXcOvdzzByj/bcfd25FOblMeXOp3nl9a85 6pjjuG7i4Qwpy0SSTJpwfpaHGdDUfGUDvPLO59x+98Nk5Rdw6aQLGDa4HAmVjVCIeT/WcPe9z1MY SfLAtWczuLxUFY7qhpQASb1dyrKkAZbmweriSV76YiFPvD6DFWujOITRnZjSPMJC246OEwnjxdeS G9nIhAN6URSM8tVnM/DCORx4eDd69t6AlVyuNE/YC2HYUpQYw9aemfRZAAAOQElEQVTjeAGPUGYx LdG+LF3cjnlzgmzanItlFCJhhrTBaZEMv/fSTmJ6CcxkM5leK1dN/APnH7cfWQFJWYmXJi1xqcpJ qe0yTKXB7njsDZ558T322ntvbrzqJPoXZNKS8upW1ia46Y7HmfHlVxw7YV+mXnEWgYwMzvrzY3y+ cCWXnX8apx87jPqGBLfe+jAffPQFxx53LFdPOpV+ReZ2h70qBi9//gPX3fc3MiMm9/zxDA7Zuzdr Kmq58toHqd1ayZSLz+DECaNUgl4l4nSNr39YzxU3PKAc/hunTOR3o8p5f85qLrnhIZKWxqTzTuDc o/akk4jM7/Tkp2aPO574mJeee5UJew3lxitOZ1CPXF6ZsYI/3fU63Ysi3HbJsewztBueY6EZARod eOLN+Tzwl9cZNbiMqVedRNdO7bj/xS+55+Fp5OblM+nsQzjzyDHkqcSuf9hJaG61SFoOz730Dk/9 9XXGHzSeG647m9I8v2m6yYGHX5jLQw+9TO/u+dz757MY0q8ztu1H9GkHf2cfTIoppJlW81hWV89j b3zGq6/MoqXFIJSRrUySLUVUgSCO7uK2/kSPPgFGD+3BhsVL+P77BXQd1I6Dj8+ha4/l2C2b0Foi GK3F6FYhWqABL3ObqvuKWV1YtaKc2d8UsWKFju1mE8rOw3LiCmCebuJZltpNBknsxiqG9e7MjVee yv5DeipwSajh2AkV5ciukSYSKXJr+e9a2jsffYOnXniT/gP6c9EZx9CrtEAtaH1TK29+PIc335uO 5iaZes2lnDJhNNvqo5xzy1N8sfgnrr30HM45ZogKIl6cNpP7Hn+BlrjDEUccysH7DKR7UR6JaAvf zFvGGx/OYMWmek78/aHcNPFQ2mcaLN5QwZTr7qeusobJF53FCYeMJWKKMnIJhHRmLl/DBVfdoXyV W/50KUeMHchPdVFuf/QDXnnrfcpKijn1uAkcOKoPwVCQ9TUNfDb3J16e9jk5GSZXnnUUpx85huwg /O3zJVxx60v0Lc3nriuPZ/yQbpK+FeVKqwdPT5vNffe+wPD+XZh69en07VXCjJV13PaXt5g+/SP6 9OzAKUcfyJ6DB5CTlUVzayszZy2hpr6Jo44ZR2V1M7dMfZqc/Gwuu+JchgzrRCIKcxf8xBN/e4+l S1YwsFcxf7rocI48aFSqqsWvXBGXRZVPb9dgCWVnsEyPVk3jzUULmXrPi6xf2Ug4u5hAIANH00lK tShRIvmtDB/dkXAizo9fLaO+sY787i7DxjcxcI+NtMvwyEh2wavvhJ4shnANreZKqpoTrFyTxw9L e7J+bS9ikiEIxTBNTZGnZjCiwGIloooHchLNuC3VnHPy0Uw+93A654VVfjigu1jJOIbkzowA2Jaq xG2wdR7461s8+sxLWI7NkF7dyMuUGjGNrVV1/LBmM9l5hfz+mCOZePph9MiPsLGikdNveIhvvlvO tRedyfnHj6c4oquI8Nl3vuC19z5nc1UDXTuXUZoXwmltYtuWjSQsGLPfgUw67/fs2S1PUScL12/j sim3UbGtkj9eeiGnHTOekOBfyrx1jS++X8WkKbcgVbLXXXkBx/1ujNLW3/ywlQeeeo2ZsxcQDpl0 LyshnJHBlupGNlU1kV8owDuIcw4fSffCDEUcP/XhfC675Wl6d23P7ZNP43ey+WQnGRB14W/TvuSO Ox5kWHl3br/+MvoOKFNk87SvV/L0C6/y03eLyNRNSjt1IRDJoqm5lTVrN9K+tD333TGRrt3KuXbq C3zxxVf06tuXfn1709QUZevWSjKzsqirraWxciUTT9yHS844hry8XGUa02TrzgCL+RX6VsDGMmyW NlQpzuT9d7/FigbJiBSqvGTciuPoLXTon0N57yy2LllLzbIooXAx8Ywkwdy1dO64hR4dwnTKLSVL K8aNh2lONFLVWsGaiiir1weor+uIq/UAaXUzmyRbiuR5whk5qtrSEg1mQLK5lvKyIm647FSO2Ks3 YenNVMrWwRW+Jk3ICgejh2j1dN77egnvfjpT5fO8aD1urJGgVM2aYTr3GsiIMWPYb69BdG0XIcv1 aGyOccdz77Fi/TaOP3AUh+81iNwsISWCrKlu5aPZy5k+4zs2bd5CrL6C/CD06lzC8KF7sM9+Y+jf rT1Bxy8TXlPTwMPPvKm6239/6IEcPG7Qdh9MEsMLVlXw3Mtvo7kWxxw0jv1GD1D0QMLV+G71Nj6d s4RZc+axaf16tXHCOfmUdinnwP334qAR3SmXTL8tUb3Ll0sqePTdWRS0y+SUo8YxqksZkvCWo9X1 +GzOfKa9Po3eJWWcdeKJdOharGicTXGHhSvWMXfmHFYuXEp1XS3NiSiZkUz69hvAkGGDOWjcYEqK 8pi7dCvvf/Q5c+fOIxFLUFRYyJAhgxg/bgxr1q5j/qyvOGBEX44/9EAKCwt9Lq1Ns8cODRb3P3VM m5jRTNwL8e7Cldz18GusXllLQM/GC0bQAjq2EaewZybBYCPN6+qgphCXdkSFTbdryQzVkx1sICvQ Sl5mEM/VaW71aEqGaYhGiHk5aMFsFYZ7ZgLMBIZsu5iB7pl4tnBuUkUooGvi7JMO5/IzDqJTbkgR o+KEulZMqWRVU6/SRtIcDI4RYFurpapTW5pbsGPNYMXRXYNQVgaFJR3Izs8mU/LL/01pRFTRHayu aVSJ3LKcEEURF81w8SwPLaOIakvKUVqoqqvDbm0mJ2hQWpBLh6JCsjKCqjxFNJI0yUQ9jc01DcTi NgXZOXQqzFDBYNrJb0hYVNU1qgR9cU4GJTkBkEpgTTZAhOq4w6aKSmpqalXVQiQzi5yCAkrb5ZCv Q1AluxsUVdJgZ7OyycYxoFNhFkWBkAKY0A1JbBqiTdRV15AbyKSkoL2qQo5pHk4gqIKdxuZWGqtr iTY3YdlxQqEQpR1KKcgrUCXXUpgoZq2yoYkN69fR2tpKQV4+nTuWkpOXRUtTK4219eSGg5QUFm5v +FAdRilfbAfAolGVKhKaK6knMbQs1jcneeSV6bz8xhdU1MYwMgsxIpm4podUXjjCCYnNT2bj2EKs iRWwMcQ1dVpwnWZM01OUluOF8LQsvxvJCKNJjZXhv/nE9ZKEghHVJGLHYxheEt1JIvURQ/r3YPLE 49l/cNft77CRV5RIhCmgUuUvYn6EQVbva9FxFGG4+3flqJq3VC29hOIBQdeubLU4MqIhbRc9lKmK MNM1Urur75LUiihSKXmRmifV0JS6j+qXFL5Ypimfa9tfYOWXGqv6GokvRTULPP6eOU+X/kgnp/Qs 4KaqsMwMxcHLf2pBU88s0britCRaT48nm8+xVbbDlU6iVL3Krv2c6Vq19JhpynvXqrEkUk+2o2Rp u7P1DzWYJRSlT5RZjl/ARzDA0i0NPPDMB7z9yRxibhBdktRSPCjCkEYBeYWTTFa0jRNVbf7iU8ju Uy1eqtXfzyuqOiNVKaG2WaoBzFEMsC5tZLZNJCJv4HFpqtpE364duPzCkzhs3z3IC/hC8ZNIqVqp 7cuuKvPbPuP/+Hfbgrp/fOI/d9Y/fdOfPfGfvV/6PBnwX+sC+CV3+tfu8PcPq3luzFNNqtKBJP2G BBTaxXLNW13FfY+8ySdfzMPIzCOYkUsslsQVcGVkSccInhXDU0V3AlKBgOSy0jlF8XJlYKklS+Wo Uq1ksvODASkJEqAl1DhWa5MqEjz7D0fxhyNGU5IhytqvEPO7E3e0+O8Q1j8PsJ9d699O+NUl4FdT OLbfqWMGSbomrZZLIKirVwh8vXgDzzz/EV8vWEJj1CIztwAzmEFLS1QlRbWIaDZpDUubnJS+SZuf dGmuAlKqo0U4G0miG1J25uHFG0g0N9Cjcyln/eE4jj1kFGXZUpPpa64db+Da+R0Sqbdd/OpC+W3A X08CmuMoY6a6TJQvo17TpKmkrMpLebB8YzVPvjSdae9+QUNcQCbOvVRXGNiBMJZ650O6Zj1tGlVc 4UNEwOUkVQmwKbS6Y2EnEqpw0IvXErQaGT64H2f84QQm7DWA3LD/UjtxkqVRQfk/baon/kUL8etJ 7beR/mkJaK3RpCdViKGgoVrz5Q2DQYny0FQDgfBUAp21VS28//lC3vzgc5asWEvMkZfRhXACGbih LFwj6Huyqvs63ZgoSVSpO3dwJaLTPdVWKTlHx0kSNDw65gfYb0RfjjviIIYM6ElWylOWigJpUZNG 2B2t12mXNvV8v5aj8E+L67cTf6kEtMaoJQEYIdNQvIzK9aloze939oQtl64VoMF2WfzjZj76ci7f zFnMxsoaGhMeUVfOkWoLydX5LxtR7yDxPAJS+I+NFY3i2VJP5qpunbKOpfTr1Yl9h5Vz8Lhh9CjJ JyGdx55HRshUGs7QPdW061e4+i/X+DsH9zeQ/dI1//96vpZ0xXuSqM8vwgsYHprklsQxVxWmaZ/K 12oCu9q4xXcrK5i76HsW/biGNVsbVDqmubmVWCyGK28nTL8AQ3MVcZoRDFGUn0vHknZ071rKsMED GTO8J93zIkSk8ztlptNtrZ56BaeU4KabQNIBdhtE7QZv/1+l99vNflYC6i3T6S7d7c60ivzSzeip cljJE6be+iwgE8YoId3RjQnWbKpj/eYKNm7aSnVNvfpc4CjMfCigk5ubSUlxId06ldK1UxmlxVnk RaTSwm/LSr/xYfs7VNPTTr/KcLt/58eS24/fAPazC/yfPkE1fey+yTJFBOxEnviLu+v56Xci2LaD Lcx26r0FQlzI6wjUa5V0v3Yr/T6R7RhKN5b+rCR+s4U/K6L/gyeoejAVpLWdXPpV3X54ueOV2Cr/ t4PdlkvSYJJo75dDIM0ft4XsrqP8T9/9H5Tob1PaSQLb29Z+k8tvEvjfkMD/A1eIsqyPQVVSAAAA AElFTkSuQmCC ------=_NextPart_000_048E_01DD4436.2447F040 Content-Type: image/png; name="image.png" Content-Transfer-Encoding: base64 Content-ID: <3276ba2e-071f-4c67-ac7f-ab8cb0b64dec> iVBORw0KGgoAAAANSUhEUgAAAJgAAAArCAYAAACEnEH6AAAAAXNSR0IArs4c6QAAIABJREFUeF7t nHeYFVW29n8VTuqcaJqmyTQZJCOgKKbBHMc05iwGTOA4hlExx+uY0zjmiDlhVnISBRSQnDvnPqnS d9euc6BhmOs44/3m/mE9Tz/dfU7Vrl1rv3uFd61Vmut5HqlDS/+lfqf+ceW3C4auznI9F00z0DQN x3VwcTF1HQ0tNYqcv+PHw0NDrg3437upn/S95Cvd8j/U5B8ZR8PzNHUPuXr7/Lb/1eZWOKkB5TI5 Vw24fQZypj9i+pk88GQSqQloRuqaXQff3c22iyp1fXrkHXP8uVH+97/faRHTK7vL719jFuk13nWs tEzkew3NSQFMfdwWG+kFsB3wbAiaapVc18HTTDRNx3JtXGwihgnIQqXAuBOKZDHl+7A/E8GD4Cl9 L7ksEAPNAs3A8wS8Op6nKyALwPyppkHS5oHUGDKYXKulAOrPpQ2E1LX+9pALUs+jQKaBLsCXa37u SD9b+jy53gfzbmb2c4P9L36/0yK2AdZuJfhvzGNXeaSHSssjDbCUClOLoOYmO1z+Sw0gGkwWw9Dw ZBF1iNsuluthBk0Cos3UKR4J2yVqJ7CcpNIqcitTDxAyAgQNE9M0Mf2VBhu8hP+HFoqD4eC5Grbt YphBND2IozCgoysNmdoAu4rElXslUgCTTWDiYe4WYJp8KptF/QjSddCDoAXS2+nvBL5DN6UgqxR+ +kdA/c9qwH9jLf+HS9P6aicNLfPbYZj8DaC0+866XIb913VvyhS1tXZqnkbqXv7omuv4M1E32m4B 0mZEPvI/dGTxxdgFdFwNLNclYTlsrGhlzYZGautaqaquZ1tFDQ3NTdiujaZ5RMIB8nIitC/KoVvX Esq7l1BWlEFuJERANzFcWWjRhN52Darpupqk64qZFIDJIqaOtlZKzdkGTcZIazBf6+1Og/m6UECW ttNpgLQZf5fb7FiANsBKaz8Z7z8MsJ2x19ZstRVU+in+N7TYTsBpA+KUBvMEYDtvg9Qi+CeIMrMV 9mS3+xaupiXB0uUbWLx0JQuXbeHHdS00trrEYnGiUQvb9tBMg2DAUCbM9VqIhG2KCk06lETo3jWf 4cP6stceQ+iR156MgIkjGsXTMJU3JyBw0HXfD/M1asrQpZSrfLRj1/pibuuv7d5E+uf5QEsL5h8L PW2a/x7dKfOqxvm/ZCL/kV+UfoJfG2C+S9322NkDE6ujAJYS+HY1JjsTXE3D9nRszfdSmpMOC1du 5tMvFzB77ves2bCNRgsSgSwwxdSIJhAzZaBrOqYEAp6D4ybAjYMXA6sZvDilZUUM7NOb/UeN4MDR e9CjXY5aqkTCJqRBJKCji3ZKO/8KUTJBU+FtV08jbXl/TuXvYuCU59hGdbeR1c4j7ao42y7ZLjL+ D//7j2bqb61f80jbgbZjtt1uvlvjuN52GOoSyfmnO2IG8aNDGWhdbQsffDafae9/xfKfNuNqYdBC xAwDNzOofDRcUYZp+y+/BRN+RKd5ogP9c9ykhWc5oLl0LIqw3579OfbQfRjRvzNZpobpuoTENLoW mjjxempSKQB7mr7bYDTtzCsN1TZSTJnPtqYzrYNk4/hPuOuRhuwOXZeGYluF/+vrhH8fAmnNu+vv f3/knXW5WLNd4Zz2SNP31jzb2aHB5Hpdw9EFXCnReR5LN23jmWmf8eZ7X1NZGyOQUYimZ4IWxgsF cAMurmfhKX/KB45EDJqYOAGd46GJ4yaq0DMJmGF0AiQSSdx4NeFgnD0G9eTkYw7lsL37UZphoLuu 8s8MPTWmejbRjgHSAEs/oMw0/WA+uFLXKJD5gYIyZZpElzvAmRoxFWGmhdfWzOzsFKfNbhsXX2n2 X1cv/BIY/L2f9Y+MZFsvbGdY/GuzT3mzO0027TCItHcAzNoBMGV6dI2kaAhNFs3j6yXLeeiFt/lq 3g80N7sEsooxQgUkYrqiK4yInNWCJyGhUlp6SuH4dsy1HAzNIBzOwHVc4vEEhkSUWgDbsjBCYFmN uPFGevXswilHHsBJB4+kW04QXTg3FW76XqCHUBgGnlybYjzSRIHnupjKisokbHDF+RdfToCVBpkf ZcqoCnpKw6YiZwGp8G7KY3CU7+d/J1HRDgImLdi0AIXk+NeW6JcAaffnetu1dIqEUbzhTjGur2E8 0d2aMjL+Inm+nP5N/1HJwhUZeyrSF4H54vSBr2ToiUfuqhhOCd0Sv0kX8Hgs+mk99/31NT6ZuQhL z0IP5eMQwfMy8MhQE9T0ZjytDrwkGgE0IhgE0dwQuCaOJTpDJ5gRwnYSOE4UM6jjOUlc0XaGge1p 6J6F01xNt/a5XHL60ZxyyCjaRWT5UryVzFEoE8PE04MkHH+Jhf8VYCUTCQK6Jl/75tER0+qbaZ8j E3AJvyaBi5ykkxoCy3HQNY2gIfNycF1bUSoyjqYiWJ/wTWuw9G8R5n8OYLJsTmoxU26I7vN/dho7 Cm0SnfvuiVBEruMT04bhb9Z/7/Cwk0lFuAcCAT8gUy6R7EgfdJrnuZ5jWUqw4qhbhk5A0/hucxX3 Pvka07+eT5NtYGYUQCAH2wvgOiaeY0oUALSCHvXNoRbEs3W8pOyoEKYRwdBNHFGSrqUAJbymptk4 iRh62MALhRRFQbSRgNuClmyid2keV5x3AkcfMJxcQ8d2bHTNUyCQB3A8DaV4BWC4BARlKgp1kWcx TAG+PKQrEvWDDwUYTQlYQKabEiwYKirebmgcTwE2nQfQZHeqDIbv3cl56bzB/wUNJkDxNa7QSCIa sTwSWPmKW3ksHgSVEvZwLBvPcQkGDRWhKwWh1PS/cvgA97WhaC4Px7bRDBPdCKh5+RrMczw5UVSd I6uv6zQkbZ564yvufeR56pvi6AUdIJCJpodxxUSl3SJxxGXhxKRaNlgJcGyQYEHZLtEwhgIY8STo JkQy/S0mTn4gAOGgcq10N07Ai2E3V+E2VXLAmCFce+mZjO1fhiPaSwSlawpktpKcT6HI/UxDBKUr HzAeT2IGgwTM1O70PFxP0lq+P+YDKK3VfIDJjxxJ2yNoaAQkFrEtDN+mtCEOfQ0hPyma9j/rg4kG S3FxtorVNDXntsZPaGj53/RE2wjAHMIhcWt898EwUym8X4gxAZArG1/JXtZYNq7ra/6U16EA5jiW b6Z1A8vTlB8+fd5P3PHgSyz6cT1GViFaOAfb1fzATOxRiqdSmRYcPCcBdisBI0YowyKSYxMIxXCd RtASBAImrqvjeiE0IxPbDqPrEWKtGo21ITy3GDMrT/lhAasZw2nFTDRw1olHc8mZR9AxL6J2pSk/ sjNdW6l82YWyORzHVUDXVWrJP9pGeio75bj+7jUNP5vgeUoLrtpaS01jKx07FFJSkENQTK4MIESx 6EiFsR1AEz8wrcnSwcW/qgN+4ZrucrpYBccnpw0/c6GA73pU1DRRUV1NZlaEDu2LyAyHfB0sPqe6 xj9bgKErn+KXH7LhVbJMg3jCoqa2Xmmw3Pwc8rKztvulmu1YyiWzNUOZxg2NMW57+C2ee+0TvHA+ kcJSEq6OlbBECaIJSaUn8BKtYEfBqSYSrKFjSYDO3bIpbu+SldtEMNxAMNKC7TSgS0RpBElYIZLJ CK6TQzhcyKq1rSycF6axpj94eegkiYQ8vEQjXryRrqUFXHXRqRy97xBCqdAkIBJ1LOWwyuIL22/Z DroZULRKzJJ0lUtDLKlAJZo5IxyiXW6YbGNHtGlbNpU19dz/2HMsWLKC439/NCcfcwB54aASjojd teMp57UtyCQVtYOq/Y/SFJ74paLFdDTD19hNCYu33/uM5158kY5lnbjkwrMZ3q8nrbYk0DzCpq/p /UDGSPmYvxxgaT80Ydts2FrNmjUbaW5soLSsI33Lu5OfGVJWRHM8xaGr8F2E9eHsH7nxvpdYuqqa YG4HCOeRVNxVEkwXLSiqtQUv2QROMx3a1TGkdwP9yk06dcolKyuJ41RgO9UEwwnMgDiUAeIJg7gV AS8fz8klFCxk4ffbmD4jzObqIbjNISJZQTTTJVpXQbu8DOItNRzxu/FMufBYehZlqR0TFFlYCUVf +MUT4sMZJF2Y890K5ny7gq11zWytaaY1IYl5naKCXAb368qIAd3o362UvJCmotv1W6u48trbmbXg eyZecDYXnXc87TLDivIQbYmbTKXw0vpQIiVB+r/rHP/yBd3tFUJii5MtYjDDSp00x5M89exr3Hf/ A/To1ZNbb7qWvYcOoCXpKtMvBPaOdFk6VfbL55NKzrGltp5FP6ylsbGVWLSF7Nx8upaVUN6xgOL8 XDTbc5UGE/O4tirOEy9+yHOvf0hcyyWYXUo0aaAMkmfjmXHl0GPVEQxEKS502WtwgrEDK8nLrMDT hVJIYotmU2ZMLJGOZxs0NMSUeczL7Ygt2sooYOHiat6fZbC5vj/o7QiGDGwrDk6ciOliRevp26MT 111xKgcN7blds+gKYJYykZ4WwsYk7sJfnnqVx5+fRlPCIZRdgBnKUo5vY30tpptk7IghnHHikew/ qic5hq5SXrO/XcbazTWM3KMXA3t3JmIYKlXuWA4hSXVtt39pXZV27/1wfIePvMNQivB3B8E0haCK CoRCSdvy7Ynov19o/24pbk9WSuiA1OgSHCUtS0XP4lgLdSPKYPGPq/huyQ+UdShmzyGDyM3NFqIA Q/PpCfG6JNOy69HWrdjxlLsHn9SwyAibaupZtGwtScvFsS3MUISOxQX06ZhPu/wcNDvpeeLb17ba vP7pSp5662O+W70UPZxLMNyRRDSIQwg9aOPpDXhuHUQ30bG4hX1GhhjRJ0pJ9hYsdxstXpKk1HEF MsnPKcOJBVj34xZaaurIyoxTXBIiJz+fuJ6P7ZaxYInDp994bK3pjhYpxRXA2A5G0MBNtBJwomSZ DldOPIWzjx5LnpkycXYCTRMq2MPTBWBBYhrc/+Q0Hn3mdbqW9+K4YybQpaRAOZ8Ll6zhrXc+oqW5 iXGjhnL95acyoKxYajCUVhRHOEuWzYmlKA4XVw+rIETAkhA2RRxYXVOBRhpKoj10Q6JUk6QbUHY1 HZWGxO1wwRYKRBzhVDZCmV/bxhOfVcI74dmMiFpFVXikuBO/Nk42kKpmkv+TjWBFIZSBZ2aTxCSW Wnu5l5ghuVTiqDgOJjq5qZnGxAJpwm/6dFSGUBZqfh6O5yr+L6gLmZTm0Pysrh8byjNYCqAqiDBN 5Z7IXOWcZNJmw+YqtmzZQlNTE+07lNKrRzcKMoMEJZp3Yp4nstxQ0cLtT8/m1a9n0+huwjMD6Fp7 vGgGaJkQEinX4nk1hKxNDO9Vx1EHQMe8GrCaSOgWNXYcJ5yPG+hAU12ELasbiFXW0iHXpXvnOO3a xxB2o5VCom45C5aYzJplUlPbFUsvwlGc047oz/Si2A1bOeeEI5hy3uF0zwuhu8LrSP2X5cfmeoAk IeKGxgPPvMvDT73O2L3HcvMfz6RvnoAPKhLw3Btf8vzLbxFrqufBO//IkaP7E7Vtpi9YTjRuMax7 B3q2i2CKj+kZOGYWa+qTfLtqG2vWrqe1toJs06VPlzJ6du1Czx5lhE0XNxlFM0Osqoyx4MfVRLKz GTKgO+vWbGPZkiXU1TcQzsqiQ5ce9OnZmf6dcwk5FnqiWZU7YYZJekHWVDbx7dIVrFu/jqRtE8jI pEPHLgwb1Ju+xRmE3WZINqlHXra+iW8r4nQq70pxXhY/LlrJ1tWrKS7OZ899htKSbOSnlUtoH85l QNfe5BUUEtchhiakEpvXVbHmx1Vsq66iKRolKyPMwL592KNPdwpzIkrTJZIOGzZu4YcflrNpy1ai CZtAJJuSTt0YMnggPTpmqgo/0YZWMkllZSVNTc20LymhqLBgu9rzk906LF1Vy58e+JiPFi7CyWyC kInm5uNFQwpgWkjkXoum1VGS1ch+Q5vZd0Q1ucEqkjGbmtYYrWaI7A6D2bApxJefrsRqtBg5IJdB vZPk5mzFDDSS8ILEvTKidGH+9wlmzTKorS7H0dsrgAk3pZSv52B4MZymbUwYM5gbJp3EyO7tlYbT SKeQhHmXCDhMQoPbn3qTB594jX3G7c2fJ59CeftcBTARwvtz13HtzffTULONh+++iRP26ceWumYu ve1plq/fyqRTD+fE340kN2wScw0Wrq7kjenzmP7NImqqa3Fb69ETjXRsl0PPHt059MgjmLDvMEoj jgouPv92DVPveVLpjvHjRvLtvAWsX7VaCb/V0cgsLGbffcZw7smHMLRHMSGVndBodAymz17GtA++ YtG331FXU4luBHGNEKHsQsbtO5aTDt6Tffp1JD8CrS0tPPjy5zz2wXyGjxxFSU6IGe98TNXaVYwc O5TJN1zG6k0reeyRxxnSvQeXnnEavfv2JApsizp8Pnc57772LisW/0izZWOJyfVsivOymXDQfvzh +IPp3a2AZcu38cijzzJr1hxcTeYTxvIMBbK9x4/nzBP2Y2zvPDLTNQiK3xZiemfTq3kpXn/G4o1M vvMN5q1cA0UGmhRHeBHcuIFOBC0olEA9UE2PMofD9rYZ2H0FEXMbrVGbygYI5vaiJVnGhx8vZ8O6 asaOGMCQfiGyQz8RDmwhGErgGGFsszNRtzMz5zcyc1aQxob+eHqJz7GpBxYtYmN6cfRYLUPKS7nx 8pM5cHAvXAUwSQs5yqkVH0/sQhSN2598k8effYfx+47jhitOpU+BmHeoScJTr3zBA4/+jR7dOnPL NRM5cGAp66taOefGx/hy4VKuufg0LjppPIUBjcVr6/nLM9N499MZZOUWMnLIAMo75hNtqGHFitUs Wrqc9l36cMl5J3H2wUMImDB3+ToumXInK1ZvpGNxEd2KcxnYrye5ubmsWL+VT2bMJxAMceqJR3PV BSfSPoLyGz9etJF7HnyOhYsWMaBvL4YN6EFubg4VjTFmLPqJTVtrGD96EFeecSgThndXvs7dr3zO n//yhsrploQ0lVbrWJDJgKEDOeqkg/l05hxuvvkhRg/oyW1XX8igAd3YmoDXPvqeBx9+lsp1axnc vzd9BvYmp7CQjRs28M3nn9GpU2duvv4yxo/uyVdz1/H0X18nmogycMhQMnOKWLOpik+/mEl1dT2n nngw110wgR7F4lz4KSM/vbYzaaOIVtlJ0+f/yB/vfpvv1tagFYbxdPFzpABMiLSgX4PvNIO7jX7l Bscc6NGjeCGWsxZHopdYCes2dGDB4lo2btvGHkPKGD2yI7lmkpDTSlCrQTdrsIIWTqiQmF3ONzN1 Zs0K09jYB1cv9sGldoAPMMONE7IaKO+QzU1XnMxhowb5jrUnbJRoAFF24idp1Htw31Pv8uwr79O3 bx9OO/YQepbmEI3HWLRsDW9//A1xR+Oc04/nkDG9Kc0Osq0uwaS7n+fTBT8w6dyTOee4ESpKffqF T7nvsefIzS9UYf7+I7vTOS8T17JYtr6Sx176lDc+mMGgPcq5f/IfGDOwMz9sq+HK6x9WABw9dCDn n3QYQ/t2JhAIsqmuiUdfms4r096hX99y7p16NYM757B4XTXX3f8Gs+cvZuSQflx+zjHsWd6eYDBA Xdxi+nebuP/RN9m4chln/+Fwrj7/KEpzAjz31Y9cdefrJOvrOGqvQVx44oF07ZBDJDOCnh3i2ffm cec9zzO0dzG3Tj6DIX068+nSSm644yXmzpnPiUfsx2VnHUy3zhJYhaisqmHe3AUqyzF+3Ci6dGxH RW2UmtpGMjJD5BcVKN+ustHi9Q8X8Nhjz9GhKMK9N1zA3sN6K4I1HQ3tBmAJcQ35cP4yrr33Pb5b 04iWn4UntVvSjKGaPCTHKCy21HVVsEdfnWN/59GlaB4JZx0Eslm1OptPPo7RHNcZNrYjewwLkRWp wIiZZDrt0JOtJLxNJIONuJKXdAcwb04+X8+IUFXXA08v9FnUtKspAPPiGNEaepZkMXXyaRw2eg/f QxOAbY/CpF5No9mDh178hIeefg3LStK9QzFB16KxsZaK6lqcYDbHnngyl114FN0zfNKxuiHKxbc/ xawl67j8wrM46fCBbNrUyI0338f8b5cxaeJ5XHzG7yiV9FaKuhUwv/d9LZfd8gSVFZv509mHcOFp h/Ldhnqm3vk4FZu2cuXE0zjt0OHpLgS1Fd5ZuJrLrrmb7Jwsbp5yPvuP7MWr079n8i2PUVhUzDWX nspp+/XEd/f9o9KD/3ptPnff/ggDu5dy29Xnsc+orrw9eyWTb3uVwrDBrZefxOFju2+vX6h24Zn3 vuOBh15mUHket045nfJOJdz97Afc/cDb9Os/gFuuOpGDh3ZAWnbEPimROi6O+IaSAVH1fLunj2dv aeXqa++navNP3HvtxRw2fqRfRSPZHNf1849trtU8Lyb8OJ8sXs6UO97i+xWNUNgO3RBHulkCYTRJ Drt+esETgPV3OfpAl7K8hQRCURpaivniy3pWrXTYY1gPBu1pogVXgl1BxMkmkizFsDxcs45EqA47 qGN7/Zg7J4dvZmZQ1ViuaApJfPsAE64toTQYrVX071TE1CmnccCI/n5vku1gGn40J2ko1zSIA/c+ +yEPPy2mI0CvLh0IajHisTitUYdN1U30GjCAY484kMPGDaBbToCNlQ1ccftjzF2yismXns/vDxvJ V19/x9Rb7yIcyeTuqddzwNDOmJKtiDejiYedWcCqxiST7nqd2XMX8fv9+3P9lLP4aWsLN9/+OFvW reemyedx3P6D0KSgQzIPOsz8aRMXTfmLiuaumXQ6+4/ux5MvfcEDT7zKXqOHc+fVZzKovQHxVrXY sqndjAzeXbqV6256gpaKddx4+Vmceuw+vDnjR66541k6tcvmrqvPYETfYhJuLZqeR5MX4en3F3Lf X15k2IB8bplyNjmZuVx9x8O8+e4CzjrzXK4650BKcyyspEVmMKiiSD2V9BI6XWJIceAlSq1obqW5 JaqqlaXAYPHGOh55+jWMWAMP/PECfjdqkEp6ih0UgEmqaDcAC/HNstVMuftN5n1fi5ZZhBbR0QNN uHaLT5l7QZBsfXIrPXs0cdh4h75lmwjq+SxdlsMXX60jIyPInuMKySpajeWsIqB7RFyTXKM9kUAY zCiJQCteKIvmaDc++9xh1rxMYu4gCLRXuS3lfxkSotsYThRaqhjTvyvXTjqZvQZ299M40umk0jh+ HY1nGkqD3fn4W/z15fcZMngw5556JP1KwiQ8jcrGJG9/PJt3PvyUzFCIKy44mdMPHUldXSuTb3uE L+d/y1WTLuCkI/fl3fc+5577H6R37z7c/McrGdKzPQGtVUXKKrkfKWZTU5wr7n+Pj7+czYTRPbnz 1olsq2nhqj89QuXmrVx94cmcfuRogqm6x6QBM1Zs4fo7nqE1nuTqy85kaL+O/Nejb/Hsy+9x/BET uPuaU+gQSEJLNQgZqmfhRLKZvb6Ze/7rRebPmM41E0/m0rN/z7Svl3HtnU+pYs1brjyD0XuU4nhV uFoRTV4uz3wwj1vv+xvDBuZz2zUXKhfnz3c9zDez13DuOecz6axx5JJQhZ2eoalWREMcec9UjyjU xLbKamYsWMysb5eyYWsNzXEPMzOXusZWNqxYweABvbl/yrns3a+rsih+4UYqwb2zBpPMs8HiVVu4 4dH3+XTORpJuNkZWBF3A4AhjL8o0iBeSmq5t5GWvYcIYj4NGZ1G1McjHHzpsqWim70CdQcMThLNX oLGVkKERdoNkmFkYAY2kE8cJRjAjXdm8pYgPP2xi0bIIbngQergdTkJqyjwIGIimNqwm3KZtHLrP CK6+6ASGdS32K5g8sG1LkYVSdiJCaQTu/+sHPPnCu4wcMZSbppzK4MIMxXUJz7W6LsY1Ux9jzow5 HHHAGG6bfBbhYIQrpj7Ip3MWcuUl53LSUfvw8fSZ3Hn3A3Tt0o1brpvC8PJiTHEX7CafZAoUsLEp xmX3vMMn38xlwuge3HPbxWyqbuCSK/6LaF09V55zAmcevRfBVEGHFJeIP3XTPU+qzqs/Xn4WQ/uV cf8jb/Hcqx9wzKEHcduVp9Atx4bWeiHdwMjEDWXyzfoGbr39WZbM/4rrJ53KxWccw7SvlzDl1scp Kwpz25VnM3ZYJzwqsWhHI7m8+OEibrzrKQb3zeWuGyYSMDO4/q5H+OzL5Zx5xplMOfcgikO2skiu Zyg+TPK4hu7zY2sqanjy+df4+NOvycgtpqBDBwKRTHLblVBT18S3cxfRv7wL9151GqPKO26PHv3K jlRtWMrMa9K1JqZmXWUDd7/wCa98vISmRA5GKIJrN2AGbfT/Fko84eFlZeHpVQS8pRw8NpsDRrRn zldrmDsvQXn/MkbtbdGuZD0aa9GdZsKatKyZyglMOHFcXaLTrjQ2d2fJ95nMnGGxsTILO9QBLZjl L6BEhq6FIflGpxmnqYIzjz1UpYu6FWSo7SU8jQp+U4V0qgJEnPy/vssTz73NiBHD+fMVJ9K3tICE 67t2EqZfc+fzfD79C4b36cpd115EYWEBE298iM/mL2PSBadz8lFj+X7Jem66+Q6amlqZ+udrOHZ8 PyJSOWBF/coRPcT3VXHOv+lZliz9gTOP2pNrrziZDRV1XHzVvTRUVnPNxadz2hFjFcDkEIBP/3Y9 19zyoOrMuv6qcxk3spynX57JbQ88w/Ahg7ltypmMK89BFy1uJXF1k2QwyCvz1nLtdQ+T6Ua5/Zpz OeqAobzyzTKmTH2azoUR7pp8BnsP6wbU4ZJHgxviqbcXcOvdzzByj/bcfd25FOblMeXOp3nl9a85 6pjjuG7i4Qwpy0SSTJpwfpaHGdDUfGUDvPLO59x+98Nk5Rdw6aQLGDa4HAmVjVCIeT/WcPe9z1MY SfLAtWczuLxUFY7qhpQASb1dyrKkAZbmweriSV76YiFPvD6DFWujOITRnZjSPMJC246OEwnjxdeS G9nIhAN6URSM8tVnM/DCORx4eDd69t6AlVyuNE/YC2HYUpQYw9aemfRZAAAOQElEQVTjeAGPUGYx LdG+LF3cjnlzgmzanItlFCJhhrTBaZEMv/fSTmJ6CcxkM5leK1dN/APnH7cfWQFJWYmXJi1xqcpJ qe0yTKXB7njsDZ558T322ntvbrzqJPoXZNKS8upW1ia46Y7HmfHlVxw7YV+mXnEWgYwMzvrzY3y+ cCWXnX8apx87jPqGBLfe+jAffPQFxx53LFdPOpV+ReZ2h70qBi9//gPX3fc3MiMm9/zxDA7Zuzdr Kmq58toHqd1ayZSLz+DECaNUgl4l4nSNr39YzxU3PKAc/hunTOR3o8p5f85qLrnhIZKWxqTzTuDc o/akk4jM7/Tkp2aPO574mJeee5UJew3lxitOZ1CPXF6ZsYI/3fU63Ysi3HbJsewztBueY6EZARod eOLN+Tzwl9cZNbiMqVedRNdO7bj/xS+55+Fp5OblM+nsQzjzyDHkqcSuf9hJaG61SFoOz730Dk/9 9XXGHzSeG647m9I8v2m6yYGHX5jLQw+9TO/u+dz757MY0q8ztu1H9GkHf2cfTIoppJlW81hWV89j b3zGq6/MoqXFIJSRrUySLUVUgSCO7uK2/kSPPgFGD+3BhsVL+P77BXQd1I6Dj8+ha4/l2C2b0Foi GK3F6FYhWqABL3ObqvuKWV1YtaKc2d8UsWKFju1mE8rOw3LiCmCebuJZltpNBknsxiqG9e7MjVee yv5DeipwSajh2AkV5ciukSYSKXJr+e9a2jsffYOnXniT/gP6c9EZx9CrtEAtaH1TK29+PIc335uO 5iaZes2lnDJhNNvqo5xzy1N8sfgnrr30HM45ZogKIl6cNpP7Hn+BlrjDEUccysH7DKR7UR6JaAvf zFvGGx/OYMWmek78/aHcNPFQ2mcaLN5QwZTr7qeusobJF53FCYeMJWKKMnIJhHRmLl/DBVfdoXyV W/50KUeMHchPdVFuf/QDXnnrfcpKijn1uAkcOKoPwVCQ9TUNfDb3J16e9jk5GSZXnnUUpx85huwg /O3zJVxx60v0Lc3nriuPZ/yQbpK+FeVKqwdPT5vNffe+wPD+XZh69en07VXCjJV13PaXt5g+/SP6 9OzAKUcfyJ6DB5CTlUVzayszZy2hpr6Jo44ZR2V1M7dMfZqc/Gwuu+JchgzrRCIKcxf8xBN/e4+l S1YwsFcxf7rocI48aFSqqsWvXBGXRZVPb9dgCWVnsEyPVk3jzUULmXrPi6xf2Ug4u5hAIANH00lK tShRIvmtDB/dkXAizo9fLaO+sY787i7DxjcxcI+NtMvwyEh2wavvhJ4shnANreZKqpoTrFyTxw9L e7J+bS9ikiEIxTBNTZGnZjCiwGIloooHchLNuC3VnHPy0Uw+93A654VVfjigu1jJOIbkzowA2Jaq xG2wdR7461s8+sxLWI7NkF7dyMuUGjGNrVV1/LBmM9l5hfz+mCOZePph9MiPsLGikdNveIhvvlvO tRedyfnHj6c4oquI8Nl3vuC19z5nc1UDXTuXUZoXwmltYtuWjSQsGLPfgUw67/fs2S1PUScL12/j sim3UbGtkj9eeiGnHTOekOBfyrx1jS++X8WkKbcgVbLXXXkBx/1ujNLW3/ywlQeeeo2ZsxcQDpl0 LyshnJHBlupGNlU1kV8owDuIcw4fSffCDEUcP/XhfC675Wl6d23P7ZNP43ey+WQnGRB14W/TvuSO Ox5kWHl3br/+MvoOKFNk87SvV/L0C6/y03eLyNRNSjt1IRDJoqm5lTVrN9K+tD333TGRrt3KuXbq C3zxxVf06tuXfn1709QUZevWSjKzsqirraWxciUTT9yHS844hry8XGUa02TrzgCL+RX6VsDGMmyW NlQpzuT9d7/FigbJiBSqvGTciuPoLXTon0N57yy2LllLzbIooXAx8Ywkwdy1dO64hR4dwnTKLSVL K8aNh2lONFLVWsGaiiir1weor+uIq/UAaXUzmyRbiuR5whk5qtrSEg1mQLK5lvKyIm647FSO2Ks3 YenNVMrWwRW+Jk3ICgejh2j1dN77egnvfjpT5fO8aD1urJGgVM2aYTr3GsiIMWPYb69BdG0XIcv1 aGyOccdz77Fi/TaOP3AUh+81iNwsISWCrKlu5aPZy5k+4zs2bd5CrL6C/CD06lzC8KF7sM9+Y+jf rT1Bxy8TXlPTwMPPvKm6239/6IEcPG7Qdh9MEsMLVlXw3Mtvo7kWxxw0jv1GD1D0QMLV+G71Nj6d s4RZc+axaf16tXHCOfmUdinnwP334qAR3SmXTL8tUb3Ll0sqePTdWRS0y+SUo8YxqksZkvCWo9X1 +GzOfKa9Po3eJWWcdeKJdOharGicTXGHhSvWMXfmHFYuXEp1XS3NiSiZkUz69hvAkGGDOWjcYEqK 8pi7dCvvf/Q5c+fOIxFLUFRYyJAhgxg/bgxr1q5j/qyvOGBEX44/9EAKCwt9Lq1Ns8cODRb3P3VM m5jRTNwL8e7Cldz18GusXllLQM/GC0bQAjq2EaewZybBYCPN6+qgphCXdkSFTbdryQzVkx1sICvQ Sl5mEM/VaW71aEqGaYhGiHk5aMFsFYZ7ZgLMBIZsu5iB7pl4tnBuUkUooGvi7JMO5/IzDqJTbkgR o+KEulZMqWRVU6/SRtIcDI4RYFurpapTW5pbsGPNYMXRXYNQVgaFJR3Izs8mU/LL/01pRFTRHayu aVSJ3LKcEEURF81w8SwPLaOIakvKUVqoqqvDbm0mJ2hQWpBLh6JCsjKCqjxFNJI0yUQ9jc01DcTi NgXZOXQqzFDBYNrJb0hYVNU1qgR9cU4GJTkBkEpgTTZAhOq4w6aKSmpqalXVQiQzi5yCAkrb5ZCv Q1AluxsUVdJgZ7OyycYxoFNhFkWBkAKY0A1JbBqiTdRV15AbyKSkoL2qQo5pHk4gqIKdxuZWGqtr iTY3YdlxQqEQpR1KKcgrUCXXUpgoZq2yoYkN69fR2tpKQV4+nTuWkpOXRUtTK4219eSGg5QUFm5v +FAdRilfbAfAolGVKhKaK6knMbQs1jcneeSV6bz8xhdU1MYwMgsxIpm4podUXjjCCYnNT2bj2EKs iRWwMcQ1dVpwnWZM01OUluOF8LQsvxvJCKNJjZXhv/nE9ZKEghHVJGLHYxheEt1JIvURQ/r3YPLE 49l/cNft77CRV5RIhCmgUuUvYn6EQVbva9FxFGG4+3flqJq3VC29hOIBQdeubLU4MqIhbRc9lKmK MNM1Urur75LUiihSKXmRmifV0JS6j+qXFL5Ypimfa9tfYOWXGqv6GokvRTULPP6eOU+X/kgnp/Qs 4KaqsMwMxcHLf2pBU88s0britCRaT48nm8+xVbbDlU6iVL3Krv2c6Vq19JhpynvXqrEkUk+2o2Rp u7P1DzWYJRSlT5RZjl/ARzDA0i0NPPDMB7z9yRxibhBdktRSPCjCkEYBeYWTTFa0jRNVbf7iU8ju Uy1eqtXfzyuqOiNVKaG2WaoBzFEMsC5tZLZNJCJv4HFpqtpE364duPzCkzhs3z3IC/hC8ZNIqVqp 7cuuKvPbPuP/+Hfbgrp/fOI/d9Y/fdOfPfGfvV/6PBnwX+sC+CV3+tfu8PcPq3luzFNNqtKBJP2G BBTaxXLNW13FfY+8ySdfzMPIzCOYkUsslsQVcGVkSccInhXDU0V3AlKBgOSy0jlF8XJlYKklS+Wo Uq1ksvODASkJEqAl1DhWa5MqEjz7D0fxhyNGU5IhytqvEPO7E3e0+O8Q1j8PsJ9d699O+NUl4FdT OLbfqWMGSbomrZZLIKirVwh8vXgDzzz/EV8vWEJj1CIztwAzmEFLS1QlRbWIaDZpDUubnJS+SZuf dGmuAlKqo0U4G0miG1J25uHFG0g0N9Cjcyln/eE4jj1kFGXZUpPpa64db+Da+R0Sqbdd/OpC+W3A X08CmuMoY6a6TJQvo17TpKmkrMpLebB8YzVPvjSdae9+QUNcQCbOvVRXGNiBMJZ650O6Zj1tGlVc 4UNEwOUkVQmwKbS6Y2EnEqpw0IvXErQaGT64H2f84QQm7DWA3LD/UjtxkqVRQfk/baon/kUL8etJ 7beR/mkJaK3RpCdViKGgoVrz5Q2DQYny0FQDgfBUAp21VS28//lC3vzgc5asWEvMkZfRhXACGbih LFwj6Huyqvs63ZgoSVSpO3dwJaLTPdVWKTlHx0kSNDw65gfYb0RfjjviIIYM6ElWylOWigJpUZNG 2B2t12mXNvV8v5aj8E+L67cTf6kEtMaoJQEYIdNQvIzK9aloze939oQtl64VoMF2WfzjZj76ci7f zFnMxsoaGhMeUVfOkWoLydX5LxtR7yDxPAJS+I+NFY3i2VJP5qpunbKOpfTr1Yl9h5Vz8Lhh9CjJ JyGdx55HRshUGs7QPdW061e4+i/X+DsH9zeQ/dI1//96vpZ0xXuSqM8vwgsYHprklsQxVxWmaZ/K 12oCu9q4xXcrK5i76HsW/biGNVsbVDqmubmVWCyGK28nTL8AQ3MVcZoRDFGUn0vHknZ071rKsMED GTO8J93zIkSk8ztlptNtrZ56BaeU4KabQNIBdhtE7QZv/1+l99vNflYC6i3T6S7d7c60ivzSzeip cljJE6be+iwgE8YoId3RjQnWbKpj/eYKNm7aSnVNvfpc4CjMfCigk5ubSUlxId06ldK1UxmlxVnk RaTSwm/LSr/xYfs7VNPTTr/KcLt/58eS24/fAPazC/yfPkE1fey+yTJFBOxEnviLu+v56Xci2LaD Lcx26r0FQlzI6wjUa5V0v3Yr/T6R7RhKN5b+rCR+s4U/K6L/gyeoejAVpLWdXPpV3X54ueOV2Cr/ t4PdlkvSYJJo75dDIM0ft4XsrqP8T9/9H5Tob1PaSQLb29Z+k8tvEvjfkMD/A1eIsqyPQVVSAAAA AElFTkSuQmCC ------=_NextPart_000_048E_01DD4436.2447F040--